- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SHR-A1811 for injection ; capecitabine
Total 1706 results
-
Henan Cancer HospitalRecruitingHER2 Low Breast CarcinomaChina
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingER Positive/HER2 Low Breast CancerChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Non-small Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2 Expression / Amplification in Patients With Biliary Tract CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Atridia Pty Ltd.RecruitingAdvanced Solid TumorsChina, Korea, Republic of, Taiwan, United States, Australia
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAdvanced Non-small Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingGastric Cancer | Colorectal CancerChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingHER2+ Gastric Cancer/Gastroesophageal Junction AdenocarcinomaChina
-
Fudan UniversityRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Enrolling by invitationAdvanced Solid TumorsChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruiting
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Enrolling by invitationAdvanced Malignant TumorsChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and TaxaneChina
-
Beijing GoBroad HospitalNot yet recruitingAdvanced Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingAdvanced Malignant TumorChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recruiting
-
Fudan UniversityActive, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2 Low Advanced or Metastatic Breast Cancer
-
Atridia Pty Ltd.CompletedSolid Tumors and Hematologic MalignancyAustralia
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recruiting
-
Guangdong Hengrui Pharmaceutical Co., LtdActive, not recruitingChronic Rhinosinusitis With Nasal PolypsChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruiting
-
Guangdong Hengrui Pharmaceutical Co., LtdEnrolling by invitationKidney TransplantationChina
-
Guangdong Hengrui Pharmaceutical Co., LtdCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Fudan UniversityRecruitingMalignant MelanomaChina
-
Fudan UniversityRecruitingAdvanced Salivary Gland CarcinomaChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Solid Tumors
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingNasopharyngeal CarcinomaChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruiting
-
Guangdong Hengrui Pharmaceutical Co., LtdNot yet recruitingEosinophilic Asthma Patients
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced Malignant Cancer
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Beijing Suncadia Pharmaceuticals Co., LtdNot yet recruiting
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Enrolling by invitationModerate to Severe Atopic DermatitisChina
-
Atridia Pty Ltd.RecruitingAlzheimer's Disease (AD)Australia
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recruiting
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recruiting
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingAdvanced Gastric Adenocarcinoma and Esophageal Squamous Cell CarcinomaChina
-
Vivozon, Inc.CompletedPost-Operative PainKorea, Republic of
-
Jiangsu Famous Medical Technology Co., Ltd.UnknownInfectious Disease
-
Huihua XiongNot yet recruiting